Articles by Erin Slifka

The hot upstarts that went public via blank-check companies are missing revenue and earnings targets—sometimes months after making those forecasts.

The one-week suspension in production of the pickup truck follows similar cuts by Ford earlier this month as auto makers deal with lingering chip shortage.

The settlement of roughly $25 billion was first announced last summer, but was given final approval by the companies after a threshold number of state and local governments agreed to participate.

Companies including Pfizer and Moderna so far have reported at least $79 billion in combined global sales of Covid-19 vaccines and treatments for 2021.

U.S. businesses operating in Russia and Ukraine are putting in place contingency plans as they are reviewing the economic impact of Moscow’s attack on its neighbor, which triggered new sanctions from the U.S., U.K. and European Union.

The deal for ADESA U.S. will help Carvana, which said its retail-sales growth flattened late last year, increase the number of cars it can sell.

The owner-operator of medical-office buildings around the country is in advanced talks to combine with a smaller rival in a deal that could create a company worth more than $10 billion.

The antitrust lawsuit argues the $13 billion tie-up would lead to higher costs.